![Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes | European Respiratory Society Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes | European Respiratory Society](https://erj.ersjournals.com/content/erj/59/1/2102730/F4.large.jpg)
Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes | European Respiratory Society
![Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes | Archivos de Bronconeumología Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes | Archivos de Bronconeumología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S0300289621003471:gr5.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9zfHQrK7O1GixshFj/RYvvhfIeFLIshOrwnoGDwJytw3P/oiFcT3h6qa0s2Be593HvpiR5a07pqsQlUEA58PYDBy9TAj902cTH2sAJRYLMSEidudlsDaRDXPz01ghWhPd19w6wLyMKK75ATyC8gkgLgdvkQBnZjOtaJqc7Tv/plB74PLh1qtKRmNeIUJ48chkp9WL/n3emGbKJ9TZz0DbOedw6GbpDQ/f1H05JuBHVFZBbEQDIGUB4bfEwCZSnstjj7XAKK2lYuYY34Pp2b49Sw=)
Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes | Archivos de Bronconeumología
![Global Initiative for Asthma (GINA) on Twitter: "GINA asthma adult and adolescent treatment is divided into two tracks, based on inhaled reliever medication. Track 1 is the approach recommended by GINA because Global Initiative for Asthma (GINA) on Twitter: "GINA asthma adult and adolescent treatment is divided into two tracks, based on inhaled reliever medication. Track 1 is the approach recommended by GINA because](https://pbs.twimg.com/media/FM7DHZNXsAA11en.jpg)
Global Initiative for Asthma (GINA) on Twitter: "GINA asthma adult and adolescent treatment is divided into two tracks, based on inhaled reliever medication. Track 1 is the approach recommended by GINA because
![2020 NAEPP Guidelines Update and GINA 2021—Asthma Care Differences, Overlap, and Challenges - ScienceDirect 2020 NAEPP Guidelines Update and GINA 2021—Asthma Care Differences, Overlap, and Challenges - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213219821011831-gr1.jpg)
2020 NAEPP Guidelines Update and GINA 2021—Asthma Care Differences, Overlap, and Challenges - ScienceDirect
![Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update | npj Primary Care Respiratory Medicine Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-023-00330-1/MediaObjects/41533_2023_330_Fig1_HTML.png)
Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update | npj Primary Care Respiratory Medicine
![GINA 2019 recommendations about reliever medications in Steps 3-5 - Global Initiative for Asthma - GINA GINA 2019 recommendations about reliever medications in Steps 3-5 - Global Initiative for Asthma - GINA](https://ginasthma.org/wp-content/uploads/2019/11/GINA-Press-Release-11-2019.png)
GINA 2019 recommendations about reliever medications in Steps 3-5 - Global Initiative for Asthma - GINA
![Section 1. EPR-3 versus GINA 2008 Guidelines - Asthma Control and Step 3 Care: Highlights of the Asthma Summit 2009: Beyond the Guidelines | World Allergy Organization Journal | Full Text Section 1. EPR-3 versus GINA 2008 Guidelines - Asthma Control and Step 3 Care: Highlights of the Asthma Summit 2009: Beyond the Guidelines | World Allergy Organization Journal | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1097%2FWOX.0b013e3181cb90c3/MediaObjects/40413_2010_208_Fig1_HTML.jpg)
Section 1. EPR-3 versus GINA 2008 Guidelines - Asthma Control and Step 3 Care: Highlights of the Asthma Summit 2009: Beyond the Guidelines | World Allergy Organization Journal | Full Text
![Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes | Archivos de Bronconeumología Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes | Archivos de Bronconeumología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S0300289621003471:gr3.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9zfHQrK7O1GixshFj/RYvvhfIeFLIshOrwnoGDwJytw3P/oiFcT3h6qa0s2Be593HvpiR5a07pqsQlUEA58PYDBy9TAj902cTH2sAJRYLMSEidudlsDaRDXPz01ghWhPd19w6wLyMKK75ATyC8gkgLgdvkQBnZjOtaJqc7Tv/plB74PLh1qtKRmNeIUJ48chkp9WL/n3emGbKJ9TZz0DbOedw6GbpDQ/f1H05JuBHVFZBbEQDIGUB4bfEwCZSnstjj7XAKK2lYuYY34Pp2b49Sw=)
Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes | Archivos de Bronconeumología
![Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes - ScienceDirect Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213219821010643-gr1.jpg)
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes - ScienceDirect
![Table 1 from Assessment of Asthma Control and Severity among Children According to Global Initiative for Asthma Guidelines in Sulaimani City-Iraq | Semantic Scholar Table 1 from Assessment of Asthma Control and Severity among Children According to Global Initiative for Asthma Guidelines in Sulaimani City-Iraq | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7929a7017c2ce99b1d7ca4991f1315e1bfb6b9a8/3-Table1-1.png)